Gilat, Ron
Haunschild, Eric D.
Patel, Sumit
Yang, JaeWon
DeBenedetti, Anne
Yanke, Adam B.
Della Valle, Craig J.
Cole, Brian J. http://orcid.org/0000-0002-4006-2113
Article History
Received: 2 September 2020
Accepted: 17 December 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: Dr. Brian Cole would like to declare the following: Previous Conflicts since 2015:Royalties from Arthrex (2015–2018) and DJO (2015/16); consulting fees from Acumed (2018), Anika Therapeutics (2015), Arthrex (2015–2018), Bioventus (2016), Flexion Therapeutics (2018), Geistlich Pharma (2016), Smith & Nephew (2017), Vericel (2016), and Zimmer Biomet (2016); speaking fees from Arthrex (2015–2018), and Lifenet Health (2017); hospitality payments from GE Healthcare (2017/2018); educational support from Medwest (2018); and honoraria from Vericel (2018). Present Conflicts: Aesculap/B.Braun: Research support, American Journal of Orthopedics: Editorial or governing board, American Journal of Sports Medicine: Editorial or governing board, Arthrex, Inc: IP royalties; Paid consultant; Research support, Arthroscopy Association of North America: Board or committee member, Athletico: Other financial or material support, Bandgrip Inc: Stock or stock Options, Cartilage: Editorial or governing board, Elsevier Publishing: IP royalties, International Cartilage Repair Society: Board or committee member, Journal of Shoulder and Elbow Surgery: Editor only: Editorial or governing board, Journal of the American Academy of Orthopaedic Surgeons: Editor only: Editorial or governing board, JRF Ortho: Other financial or material support, National Institutes of Health (NIAMS & NICHD): Research support, Operative Techniques in Sports Medicine: Publishing royalties, financial or material support, Ossio: Stock or stock Options, Regentis: Paid consultant; Research support; Stock or stock Options, Smith & Nephew: Other financial or material supportDr. Adam Yanke would like to declare the following: Dr. Yanke reports grants from Arthrex, Inc, other from JRF Ortho, other from Olympus, grants from Organogenesis, other from Patient IQ, other from Smith & Nephew, other from Sparta Biomedical, grants from Vericel, outside the submitted work; Arthrex, Inc: Research support, CONMED Linvatec: Paid consultant, JRF Ortho: Paid consultant, Olympus: Paid consultant, Organogenesis: Research support, Patient IQ: Unpaid consultant, PatientIQ: Stock or stock Options, Smith & Nephew: Unpaid consultant, Sparta Biomedical: Unpaid consultant, Vericel: Research supportDr. Craig Della Valle would like to declare the following: Dr. Della Valle reports personal fees from Consulting, personal fees from Patents, personal fees from Royalties, personal fees from Stock/Stock options, other from Research Support, outside the submitted work; American Association of Hip and Knee Surgeons: Board or committee member, Arthritis Foundation: Board or committee member, DePuy, A Johnson & Johnson Company: Paid consultant, Hip Society: Board or committee member, Orthopedics Today: Editorial or governing board, Orthophor and Surgiphor: Stock or stock Options, Parvizi Surgical Innovations: Stock or stock Options, SLACK Incorporated: Editorial or governing board; Publishing royalties, financial or material support, Smith & Nephew: IP royalties; Paid consultant; Research support, Stryker: Research support, Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties, financial or material support, Zimmer: IP royalties; Paid consultant; Research support.
: N/A
: All the authors consent to publication.
: N/A